SEC
SlamSEC
SearchBrowseEarnings

Biohaven Ltd.

NYSE:BHVN
Pharmaceutical Preparations·NEW HAVEN, CT
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(249 total)

TypeDateAccessionPeriodSize
4/A
Mar 9, 2026
0001027035-26-000006FORM 4/A
Mar 4, 2025
6.7 KB
4
Mar 3, 2026
0001898799-26-000004FORM 4
Feb 27, 2026
5.3 KB
4
Mar 3, 2026
0001704186-26-000004FORM 4
Feb 27, 2026
5.3 KB
4
Mar 3, 2026
0001878290-26-000004FORM 4
Feb 27, 2026
5.3 KB
4
Mar 3, 2026
0001798876-26-000004FORM 4
Feb 27, 2026
5.3 KB
4
Mar 3, 2026
0001704317-26-000004FORM 4
Feb 27, 2026
5.3 KB
8-K
Mar 2, 2026
0001935979-26-0000228-K
Mar 2, 2026
332.8 KB
S-8
Mar 2, 2026
0001935979-26-000021S-8
—
316.0 KB
10-K
Mar 2, 2026
0001935979-26-00002010-K
Dec 31, 2025
47.6 MB
SCHEDULE 13G/A
Feb 13, 2026
0000919574-26-000942
—
16.5 KB
SCHEDULE 13G/A
Feb 6, 2026
0001274173-26-000045
—
11.7 KB
8-K
Jan 12, 2026
0001935979-26-0000058-K
Jan 12, 2026
14.3 MB
4
Jan 7, 2026
0001704186-26-000002FORM 4
Jan 5, 2026
8.5 KB
4
Jan 7, 2026
0001898799-26-000002FORM 4
Jan 5, 2026
8.7 KB
4
Jan 7, 2026
0001704317-26-000002FORM 4
Jan 5, 2026
11.2 KB
4
Jan 7, 2026
0001798876-26-000002FORM 4
Jan 5, 2026
9.4 KB
4
Jan 7, 2026
0001878290-26-000002FORM 4
Jan 5, 2026
9.1 KB
8-K
Jan 7, 2026
0001935979-26-0000028-K
Jan 6, 2026
128.8 KB
4
Nov 18, 2025
0001878290-25-000004FORM 4
Nov 17, 2025
5.8 KB
4
Nov 17, 2025
0001935979-25-000096FORM 4
Nov 13, 2025
4.5 KB
4
Nov 17, 2025
0001027035-25-000004FORM 4
Nov 13, 2025
7.4 KB
4
Nov 17, 2025
0001704317-25-000004FORM 4
Nov 13, 2025
8.3 KB
SCHEDULE 13G
Nov 14, 2025
0001274173-25-000271
—
9.2 KB
8-K
Nov 13, 2025
0001628280-25-0520668-K
Nov 13, 2025
554.3 KB
424B5
Nov 13, 2025
0001628280-25-051841424B5
—
780.0 KB
25 filings shown
CEO
Coric Vlad
CFO
Buten Matthew